Basel Medical Group Ltd - Ordinary Shares with no par value (BMGL)

CUSIP: G0864B103

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Ordinary Shares with no par value
Shares outstanding
18,772,286
Total 13F shares
143,220
Share change
-146,252
Total reported value
$70,178
Price per share
$0.49
Number of holders
8
Value change
-$322,542
Number of buys
6
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP G0864B103?
CUSIP G0864B103 identifies BMGL - Basel Medical Group Ltd - Ordinary Shares with no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Basel Medical Group Ltd - Ordinary Shares with no par value (BMGL) as of Q4 2025

As of 31 Dec 2025, Basel Medical Group Ltd - Ordinary Shares with no par value (BMGL) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 143,220 shares. The largest 8 holders included Ground Swell Capital, LLC, XTX Topco Ltd, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, and Bell Investment Advisors, Inc. This page lists 8 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.